CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)	12 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Cash flows from operating activities:
Net loss	$ (7,150,712)	$ (10,515,124)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	313,940	367,556
Fair value of vested options issued to officers, directors and employees	1,953,844	1,485,068
Amortization of capitalized financing costs	85,975	858,985
Amortization of debt discount attributable to convertible debentures	541,120	2,096,427
Equity based compensation	58,238	1,444,583
Common stock issued in settlement of interest	102,844	36,997
Fair value change from employee option modifications		738,810
Change in operating assets and liabilities:
Increase in accounts receivable	(88,407)	(145,558)
(Increase) decrease in prepaid expenses and deposits	(16,565)	70,030
Increase (decrease) in accounts payable and accrued liabilities	239,044	(199,490)
Net cash used in operating activities	(3,960,679)	(3,761,716)
Cash flows from investing activities:
Purchase of property and equipment	(162,833)	(89,108)
Net cash used in investing activities	(162,833)	(89,108)
Cash flows from financing activities:
Net proceeds from (payments of) related party advances		(50,000)
Net proceeds from sale of common stock	2,101,000	4,735,000
Net proceeds from issuance of convertible notes		1,895,500
Net cash provided by financing activities	2,101,000	6,580,500
Net (decrease) increase in cash and cash equivalents	(2,022,512)	2,729,676
Cash and cash equivalents at beginning of year	2,747,294	17,618
Cash and cash equivalents at end of year	724,782	2,747,294
Supplemental Disclosures of Cash Flow Information:
Cash paid during period for interest
Cash paid during period for income taxes
Non-cash investing and financing transactions:
Fair value of warrants issued for financing costs		217,971
Common stock issued in exchange for previously incurred debt and related accrued interest	$ 4,687,096	$ 373,000